Nittaya Limsuwanachot
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Committed change of real-time quantitative PCR to droplet digital PCR for monitoring BCR::ABL1 transcripts in tyrosine kinase inhibitor treated CML.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 11, 2023
A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia.
Journal: Journal of mass spectrometry and advances in the clinical lab
Published: August 24, 2022
TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Journal: Diagnostic pathology
Published: January 14, 2021
Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A Single-Center Experience in Thailand.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: February 07, 2020
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia.
Journal: Experimental hematology & oncology
Published: December 15, 2018
Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 14, 2017
Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 29, 2016
Multiplex RT-PCR Assay for Detection of Common Fusion Transcripts in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Cases.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: March 02, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026